Alignment Healthcare, Inc.
HealthcareNASDAQ:ALHC · NASDAQ Global Select
-$0.49 today
Vol 4.31M · Avg 5.26M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-0.4%
avg -52.5%
ROIC
2.5%
avg -25.7%
ROA
-0.1%
avg -18.0%
Analysis
ROIC is currently the strongest return metric at 2.5% versus its period average of -25.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
John E. Kao | Founder, Chairman & CEO | $2.78M | — | 64 | $1.39M | 0.67% |
Dawn Christine Maroney | President | $1.74M | — | 58 | $977,313.00 | 0.47% |
Hyong J. Kim | Chief Medical Officer | $1.33M | — | 56 | $0.00 | <0.01% |
Christopher J. Joyce | Chief Legal & Administrative Officer | $1.30M | — | 62 | $0.00 | <0.01% |
James Head | Chief Financial Officer | $1.03M | — | 60 | $173,495.00 | 0.08% |
Andreas Wagner | Chief Human Resources Officer | $850,162.00 | — | 56 | $148,628.00 | 0.07% |
Joseph Samuel Konowiecki | Vice Chairman & Executive VP of Corporate Affairs | $100,000.00 | — | 72 | $1.18M | 0.57% |
Kerry Matsumoto | Senior Vice President of Clinical Product | — | — | — | — | — |
Randall Fitzpatrick | Senior Vice President of Product | — | — | — | — | — |
Rob Scavo | Chief Information Officer | — | — | 61 | $487,685.00 | 0.24% |
Sergio Zaldivar | Senior Vice President of Business Operations | — | — | — | — | — |
Donald S. Furman | Co-Founder & Chief Clinical Officer | — | — | 75 | $1.53M | 0.74% |
Todd Macaluso | Chief Growth Officer of Health Plan | — | — | — | — | — |
Shane Hochradel | Chief Operations Officer | — | — | — | $0.00 | <0.01% |
Dan Peterson | President of Arizona Market | — | — | — | — | — |
Rich Powers | Senior Vice President of Business Development | — | — | — | — | — |
David Milligan | Senior Vice President of Sales for California | — | — | — | $173,408.00 | 0.08% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$197,626.88
Sells
95
$1.15B
Net Sentiment
$1.15B
Net selling
Most Active
KAO JOHN E
28 transactions
1–10 of 96
Analysis
Insiders reported 1 buys worth $197,626.88 and 95 sells worth $1.15B over the last 12 months. That adds up to net selling of $1.15B. KAO JOHN E was the most active insider with 28 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +23.9% | +33.4% (7yr)3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | N/A | N/A3 analysts |
Analysis
Recent growth has been strongest in Revenue at +23.9% over three years. Forward estimates point to Revenue at +33.4% (7yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Oscar Health, Inc.
NYSE:OSCR
$7.33B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.47B
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
$4.99B
Envista Holdings Corp
NYSE:NVST
$4.00B
ICU Medical, Inc.
NASDAQ:ICUI
$3.55B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.01B
Privia Health Group, Inc.
NASDAQ:PRVA
$2.95B
Soleno Therapeutics, Inc.
SLNO
$2.76B
GRAIL, Inc.
NASDAQ:GRAL
$2.57B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.40B
Who manages ALHC?
Alignment Healthcare, Inc. (ALHC) lists 17 active executives. The top listed executive is Andreas Wagner, Chief Human Resources Officer.
Are ALHC insiders buying or selling?
Recent insider activity shows net selling of $1.69B.
Explore More
Continue the stock analysis
Jump to another research area for this company.